• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23533 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Guidance on the use of glycoprotein IIb/IIIa inhibitors
2002     Institute for Clinical Systems Improvement (ICSI) Left ventricular assist devices as permanent implants
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Home compared with hospital haemodialysis for patients with end-stage renal failure
2002     Institute for Clinical Systems Improvement (ICSI) Lymphatic mapping with sentinel lymph node biopsy for breast cancer
2002     HAYES, Inc. Fetoscopic laser surgery for twin-twin transfusion syndrome
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of imatinib for chronic myeloid leukaemia
2002     Basque Office for Health Technology Assessment (OSTEBA) [The identification of emerging health technologies. Document for the SorTek network]
2002     The Swedish Council on Health Technology Assessment (SBU) Endoscopic transthoracic sympathectomy (ETS) - early assessment briefs (ALERT)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Organisation of services for diabetic retinopathy screening: HTA Advice 1: Organisation of services for diabetic retinopathy screening: Understanding HTBS Advice: Diabetic retinopathy screening in Scotland
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of computerized cognitive-behavioural therapy for anxiety and depression
2002     The Swedish Council on Health Technology Assessment (SBU) Endovascular surgery for abdominal aortic aneurysm - early assessment briefs (ALERT)
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Positron emission tomography (PET) imaging in cancer management; HTA Advice 2: Positron emission tomography (PET) imaging in cancer management; Understanding HTBS Advice; Use of PET imaging for cancer in Scotland. Amendment to full report published July 2005.
2002     Institute for Clinical Systems Improvement (ICSI) Pancreatic islet transplantation for patients with type 1 diabetes mellitus
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of drugs for early thrombolysis in the treatment of acute myocardial infarction
2002     WorkSafeBC Marijuana for medicinal purposes: an evidence-based assessment
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Injury in Israel
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Sex change surgery - expert panel. IPE-02/i
2002     HAYES, Inc. Gastric electrical stimulation for gastroparesis
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of long-acting insulin analogues for the treatment of diabetes - insulin glargine
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Medical management of terrorist attacks
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) The use of vinorelbine for the treatment of advanced breast cancer
2002     The Swedish Council on Health Technology Assessment (SBU) Pallidotomy in Parkinson's disease - early assessment briefs (ALERT)
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) When is an epidemic an epidemic?
2002     Institute for Clinical Systems Improvement (ICSI) Photodynamic therapy for head and neck, tracheobronchial, and esophageal cancer
2002     Institute for Clinical Effectiveness and Health Policy (IECS) AMS 800 artificial urinary sphincter for children with urinary incontinence
2002     The Swedish Council on Health Technology Assessment (SBU) The ketogenic diet for epilepsy - early assessment briefs (ALERT)
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Diabolocal, haunting terror - here and now
2002     Institute for Clinical Systems Improvement (ICSI) Prenatal ultrasound as a screening test
2002     Andalusian Health Technology Assessment Area (AETSA) Appropriate use of short-cycle sterilization (flash sterilization) in non-urgent ophthalmological surgery - non-systematic review
2002     HAYES, Inc. Genetic testing for susceptibility to breast cancer
2002     Israel Center for Technology Assessment in Health Care (ICTAHC) Hospital management of a bioterror event
2002     Institute for Clinical Systems Improvement (ICSI) Serum antibodies for the diagnosis of inflammatory bowel disease (IBD): pANCA for ulcerative colitis (UC) and ASCA for Crohn's disease (CD)
2002     Andalusian Health Technology Assessment Area (AETSA) Report on the hearing-aid device AUDIGITAL ALFA 128
2002     Medical Services Advisory Committee (MSAC) Liquid based cytology for cervical screening
2002     Medical Services Advisory Committee (MSAC) Human papillomavirus testing in women with cytological prediction of low-grade abnormality
2002     Medical Services Advisory Committee (MSAC) Intravascular brachytherapy
2002     Medical Services Advisory Committee (MSAC) Magnetic resonance imaging for cholangeopancreatography
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Air travel as a risk factor for venous thromboembolism (VTE) and the effectiveness of preventive measures
2002     Medical Services Advisory Committee (MSAC) Percutaneous transluminal coronary rotational atherectomy for lesions of the coronary arteries
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Carotid stenting for the treatment of carotid artery stenosis
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Expandable metal stents for inoperable oesophageal cancer
2002     Medical Services Advisory Committee (MSAC) Recombinant human thyroid-stimulating hormone (rhTSH). Diagnostic agent for use in well-differentiated thyroid cancer
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Deep brain stimulation for patients with Parkinson's disease
2002     West Midlands Health Technology Assessment Collaboration (WMHTAC) Fludarabine as first line therapy for chronic lymphocytic leukaemia
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Photonic stimulation for the treatment of chronic pain
2002     Medical Services Advisory Committee (MSAC) Transoesophageal echocardiography
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Spinal manipulation for lower back pain
2002     Medical Services Advisory Committee (MSAC) Selective internal radiation therapy for hepatic metastases using SIR-Spheres(R)
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Ultrasonic cutting and coagulating devices
2002     Medical Services Advisory Committee (MSAC) M-VAX(TM) - a treatment for patients with advanced stage III melanoma
2002     NIHR Health Technology Assessment programme Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment
2002     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) Assessment of the effectiveness of health promotion and disease prevention technologies. IPE-02/36 (Public report)
2002     NIHR Health Technology Assessment programme Rituximab as third-line treatment for refractory or recurrent Stage III or IV follicular non-Hodgkin's lymphoma: a systematic review and economic evaluation
2002     Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS) Beta-interferon and glatiramer acetate for the treatment of multiple sclerosis
2002     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity: a technology assessment
2002     NIHR Health Technology Assessment programme The cost-effectiveness of magnetic resonance angiography for carotid artery stenosis and peripheral vascular disease: a systematic review
2002     ECRI Helical CT for detection of lung cancer
2002     Agency for Healthcare Research and Quality (AHRQ) Current validity of AHRQ clinical practice guidelines
2002     NIHR Health Technology Assessment programme Promoting physical activity in South Asian Muslim women through 'exercise on prescription'
2002     NIHR Health Technology Assessment programme A review of the natural history and epidemiology of multiple sclerosis: implications for resource allocation and health economic models
2002     ECRI High-dose chemotherapy and stem cell transplantation for the treatment of systemic lupus erythematosus
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Extracorporeal immunoadsorption treatment for rheumatoid arthritis
2002     ECRI High dose chemotherapy with allogeneic stem cell transplantation for Hodgkin's disease
2002     The Netherlands Organisation for Health Research and Development (ZonMw) [Gynecological cancer: diagnostic value of radiological tests]
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Computer-enhanced surgical systems ('robotic surgery')
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Activated protein C for severe sepsis
2002     The Swedish Council on Health Technology Assessment (SBU) Tobacco smoking and oral health
2002     ECRI High-dose chemotherapy with autologous or allogeneic bone marrow or peripheral stem cell transplantation of neuroblastoma
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) An assessment of oseltamivir for the treatment of suspected influenza
2002     HAYES, Inc. Home uterine activity monitoring
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Clinical and economic assessment: infliximab for the treatment of Crohn's disease
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Infliximab for the treatment of Crohn's disease: a systematic review and cost-utility analysis
2002     The Swedish Council on Health Technology Assessment (SBU) Prevention, diagnosis, and treatment of venous thromboembolism
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Radiofrequency catheter ablation for cardiac arrhythmias: a clinical and economic review
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Application of an assessment framework to an evolving telemental health program
2002     Alberta Heritage Foundation for Medical Research (AHFMR) A study of the impact of 2000-2001 HTA products
2002     Basque Office for Health Technology Assessment (OSTEBA) [Endoscopic and radiological techniques in the diagnosis and screening of colon cancer. Evaluation of the variability of use and acceptabilityy]
2002     HAYES, Inc. Hyperthermia treatment for cancer, whole body
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Surgical treatment for chronic venous insufficiency
2002     Basque Office for Health Technology Assessment (OSTEBA) [Low molecular weight heparins versus traditional heparins in thromboembolic diseases]
2002     New Zealand Health Technology Assessment (NZHTA) Are different triage models associated with different outcomes in people presenting following suicidal ideation/threat/attempt? Evidence Tables
2002     Basque Office for Health Technology Assessment (OSTEBA) [The effectiveness and safety of different forms of treating prostate cancer]
2002     New Zealand Health Technology Assessment (NZHTA) Are there any crisis containment drug treatments that have been shown to be useful for reducing suicidality in short-term crises? Evidence Tables
2002     New Zealand Health Technology Assessment (NZHTA) Are there any drug treatments that have been shown to increase the risk of suicide? Evidence Tables
2002     New Zealand Health Technology Assessment (NZHTA) Does asking about suicidal ideation increase the likelihood of suicide attempts? Evidence Tables
2002     The Swedish Council on Health Technology Assessment (SBU) Hormone replacement therapy
2002     New Zealand Health Technology Assessment (NZHTA) Is there any evidence regarding the competency of different clinicians to do adequate suicide risk assessments? Evidence Tables
2002     The Swedish Council on Health Technology Assessment (SBU) Obesity - problems and interventions
2002     New Zealand Health Technology Assessment (NZHTA) What are the characteristics of repeating vs. non-repeating suicidal presenters to Emergency services? Evidence Tables
2002     New Zealand Health Technology Assessment (NZHTA) What are the presenting complaints that should alert clinicians in emergency departments and tertiary mental health settings to the possibility of suicidal ideation/threat/attempts? Evidence Tables
2002     University of York Homeopathy
2002     New Zealand Health Technology Assessment (NZHTA) What evidence is there about the use of seclusion or containment for patients presenting with suicidal behaviours at emergency departments, tertiary mental health services or inpatient units? Evidence Tables
2002     University of York Interventions for the management of CFS/ME
2002     New Zealand Health Technology Assessment (NZHTA) What factors determine an inpatient admission as opposed to outpatient referral from emergency services? Evidence Tables
2002     Alberta Heritage Foundation for Medical Research (AHFMR) Acupuncture: evidence from systematic reviews and meta-analyses
2002     New Zealand Health Technology Assessment (NZHTA) What is the effectiveness of day care versus outpatient care versus community care for suicidal patients? Evidence Tables
2002     New Zealand Health Technology Assessment (NZHTA) What is the efficacy of crisis interventions? Evidence Tables
2002     New Zealand Health Technology Assessment (NZHTA) What is the efficacy of discharge planning protocols, i.e., managing the transition from hospital to community? What should be included in the plan? Evidence Tables
2002     Medical Advisory Secretariat (MAS) Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis
2002     Agency for Healthcare Research and Quality (AHRQ) Systems to rate the strength of scientific evidence